Target intelligence / Profile preview

Intestinal mucosal microcirculation (IMM)

Target
IMM
Molecular classification
Other
01

Overview

The intestinal mucosal microcirculation is a specialized vascular system consisting of arterioles, capillaries, and venules that provide essential perfusion to the innermost layers of the gut wall. This system is critical for nutrient absorption, the delivery of oxygen to the highly metabolic intestinal epithelium, and the regulation of the mucosal immune response [1, 3, 12]. It also plays a fundamental role in maintaining the intestinal barrier, preventing the translocation of luminal toxins and pathogens into the systemic circulation [7, 14]. In pathological states such as sepsis, shock, and inflammatory bowel disease (IBD), microvascular dysfunction leads to impaired capillary density and increased permeability, causing tissue hypoxia and organ injury [4, 12]. While not a single molecular target, it is a primary physiological endpoint for therapeutic strategies using vasodilators, fluids, and anti-inflammatory agents to restore gut integrity [10, 15]. Clinical monitoring often relies on indirect biomarkers like I-FABP or surrogate imaging of the sublingual microvascular flow [12].

Other names
Intestinal microvasculatureGastrointestinal microcirculationMucosal microcirculatory bedGut microcirculation
02

Mechanism of action

Drugs modulate the intestinal mucosal microcirculation by regulating vascular tone through adrenergic or nitric oxide pathways, inhibiting leukocyte adhesion to the endothelium, and reducing pro-inflammatory cytokine-mediated microvascular leak to maintain tissue oxygenation [10, 15].

03

Biological functions

Immune responseOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Systemic hypotension from vasodilationParadoxical mesenteric ischemia due to vasopressor-induced shuntingReperfusion-induced oxidative injury
06

Interacting drugs

Nitroglycerin

6 more in the full profile.

07

Biomarkers

Intestinal fatty acid-binding protein (I-FABP)Sublingual microcirculation (surrogate)Gastric-to-arterial pCO2 gapSerum L-lactate

Beyond the preview

Go deeper on Intestinal mucosal microcirculation (IMM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mucosal microcirculation (IMM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call